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Pulmonary tuberculosis (TB) is caused by inhalation of Mycobacterium tuberculosis, 
which damages the bronchial epithelial barrier to establish local infection. Matrix metal-
loproteinase-1 plays a crucial role in the immunopathology of TB, causing breakdown 
of type I collagen and cavitation, but this collagenase is also potentially involved in bron-
chial epithelial repair. We hypothesized that the extracellular matrix (ECM) modulates 
M. tuberculosis-driven matrix metalloproteinase-1 expression by human bronchial epi-
thelial cells (HBECs), regulating respiratory epithelial cell migration and repair. Medium 
from monocytes stimulated with M. tuberculosis induced collagenase activity in bronchial 
epithelial cells, which was reduced by ~87% when cells were cultured on a type I  collagen 
matrix. Matrix metalloproteinase-1 had a focal localization, which is consistent with cell 
migration, and overall secretion decreased by 32% on type I collagen. There were no 
associated changes in the specific tissue inhibitors of metalloproteinases. Decreased 
matrix metalloproteinase-1 secretion was due to ligand-binding to the α2β1 integrin and 
was dependent on the actin cytoskeleton. In lung biopsies, samples from patients with 
pulmonary TB, integrin α2β1 is highly expressed on the bronchial epithelium. Areas of 
lung with disrupted collagen matrix showed an increase in matrix metalloproteinases-1 
expression compared with areas where collagen was comparable to control lung. Type 
I collagen matrix increased respiratory epithelial cell migration in a wound-healing assay, 
and this too was matrix metalloproteinase-dependent, since it was blocked by the matrix 
metalloproteinase inhibitor GM6001. In summary, we report a novel mechanism by which 
α2β1-mediated signals from the ECM modulate matrix metalloproteinase-1 secretion by 
HBECs, regulating their migration and epithelial repair in TB.
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inTrODUcTiOn
Tuberculosis (TB) is a global health problem, with 8.6 million new cases per year, of which an 
increasing proportion are caused by multi-drug-resistant organisms (1). TB primarily causes 
disease in the lungs (2). Pulmonary cavitation, characterized by extracellular matrix (ECM) 
destruction and lung remodeling results in patient morbidity and mortality (3, 4). Pulmonary 
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ECM is composed of a network of molecules including type I, 
III, and IV collagen, fibronectin, and laminin (5). Type I colla-
gen is the primary structural fibril of the lung, provides tensile 
strength, and is highly resistant to enzymatic degradation (6). 
Besides contributing to the biochemical and biomechanical 
properties of the lung, the ECM also regulates cellular com-
munication and has important roles in regulation of immune 
responses (7–9).
Matrix metalloproteinases (MMPs) are key in TB-associated 
tissue destruction and include collagenases, such as MMP-1, 
which are able to degrade fibrillar type I collagen (10–13). Our 
group has demonstrated that in pulmonary TB, MMP-1 is the 
key in the immunopathology of disease and is expressed within 
TB granulomas and in adjacent airway epithelial cells (10, 14). 
MMP gene expression is upregulated by diverse stimuli includ-
ing cytokines and cell–cell interactions (15). MMP activity is 
specifically inhibited by a family of four tissue inhibitors of 
metalloproteinases (TIMPs) (16, 17). In TB, cell–cell interactions 
involving infected and un-infected phagocytic and stromal cells, 
including respiratory epithelial cells, drive MMP secretion and 
amplify ECM destruction (18–20).
Despite playing important roles in tissue destruction, MMPs 
are increasingly recognized as key elements in tissue repair. 
Following airway injury, cell migration is one of the first events 
leading to re-epithelialization (21–23). Cell spreading and 
migration require attachment to the ECM. MMP-1 and 9 may 
regulate migration of the cells involved in lung epithelial repair 
by remodeling the ECM (23, 24). MMP-1 has been shown to 
promote alveolar epithelial cell migration, wound closure, and 
protection from apoptosis (25). Following TB, tissue repair is 
key but substantial tissue remodeling may result in cavitation, 
fibrosis, airway narrowing, and bronchiectasis (3).
Cell adhesion to the ECM is mediated by integrins, which 
recruit cytoplasmic signaling complexes, comprised of adaptor 
proteins and signaling molecules, which link integrins to the 
actin cytoskeleton (26). Such assembly is dependent on combi-
nations of integrin occupancy and/or clustering resulting in a 
complex hierarchy of downstream events (27), which regulate 
many aspects of cell function including MMP expression in 
response to matrix binding (24, 28, 29). Integrin α2β1 and α3β1 
bind to collagens and are constitutively expressed by respiratory 
epithelial cells (30). Integrin α2β1 has a high affinity to type I 
collagen, while α3β1 also binds other matrix components such as 
laminins and fibronectin (31, 32).
According to the pattern of expression and activation state, 
integrins may play important roles in normal tissue homeostasis 
and tissue repair, or contribute to the development of inflam-
matory diseases, such as asthma or pulmonary fibrosis (33). For 
example, the Th2 cytokines IL-4 and IL-13 have been shown 
to decrease lung epithelial repair in wound healing assays due 
to decreased expression of integrin α2β1 at the leading edge of 
epithelial cells (34), while induction of integrin αvβ6 leads to 
intraepithelial activation of TGF-β and modulation of mast cell 
protease expression, which may regulate airway responsiveness 
in allergic asthma. On the other hand, integrin αvβ6 signaling 
may have a protective role against emphysema, by decreasing 
MMP-12 expression (35).
In the present study, we investigated the hypothesis that the 
local ECM has a key role in modulation of MMP secretion from 
the respiratory epithelium. In our cellular model of pulmonary 
TB, we investigated the effect on MMP release of integrin-
mediated adhesion of epithelial cells to a type I collagen matrix. 
We demonstrated that, in TB, bronchial epithelial cell adhesion 
to a collagen matrix is able to modulate both MMP-1 expres-
sion and epithelial repair, signaling through α2β1 and the actin 
cytoskeleton. In contrast, absence of such cell–matrix interac-
tions leads to upregulation of MMP-1, which is known to drive 
TB immunopathology.
MaTerials anD MeThODs
reagents
The broad spectrum MMP inhibitor GM6001 was from 
Calbiochem (Hertfordshire, UK). FITC-conjugated anti-integrin 
α2 (clone AK7, Abcam, Cambridge, UK), anti-integrin α3 (clone 
17C6, Abcam), and IgG1 isotype control antibodies (BD 
Biosciences, Oxford, UK) were used in FACS assays. Anti-integrin 
α2β1 (clone BHA2.1) and anti-integrin α3β1 (clone M-KID2) 
antibodies were from Millipore (Hertfordshire, UK). Rabbit anti-
MMP-1 primary antibody (Millipore) and Cy5-goat anti-rabbit 
IgG (Abcam) secondary antibody were used in confocal assays. 
Phalloidin conjugated with Alexa Fluor 594 (Thermo Fisher 
Scientific, Paisley, UK) was used for F-actin staining and DAPI 
was used as nuclear counterstain. Other reagents were purchased 
from Sigma-Aldrich (Dorset, UK) unless otherwise stated.
cell culture
Primary human bronchial epithelial cells (HBECs) were cultured 
in BEGM (Lonza, Basel, Switzerland) according to supplier’s 
instructions. All experiments were performed between passages 
4 and 5. Subcultures were performed when cells were 70–80% 
confluent and seeded at a density of 42,500  cells/cm2. Cells 
were stimulated with 1:5 dilution of CoMtb or control medium 
(CoMCont). Cell viability was performed by trypan blue 
exclusion.
conditioned Media Preparation (coMtb)
CoMtb was prepared as previously described (36). In brief, 
monocytes from single-donor leukocyte cones (National Blood 
Transfusion Service, London, UK) were isolated by gradient cen-
trifugation with Ficoll-Paque (GE Healthcare, Buckinghamshire, 
UK) and adhesion purification. Monocytes were seeded at a den-
sity of 2.5 × 105 cells/cm2 in 60 mm petri dishes. Non-adherent 
cells were removed by washing with HBSS (Thermo Fisher 
Scientific, Paisley, UK). Fresh RPMI medium (Thermo Fisher 
Scientific) supplemented with 2  mM glutamine and 10  mg/ml 
ampicillin was added to cells before infecting with Mtb strain 
H37Rv at a multiplicity of infection of one and incubation over-
night at 37°C and 5% CO2. Supernatants were collected, filtered 
through a 0.2  µm polypropylene filter (Whatman Anotop 25, 
Buckinghamshire, UK), aliquoted, and stored at −20°C. CoMtb 
contains both host-derived cytokines and chemokines (e.g., TNF-α, 
IL-1β, and IL-6) and pathogen-derived antigens and lipids (20). 
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CoMCont was prepared in the same manner but in the absence 
of Mtb infection.
coating of Tissue culture Plates
Tissue culture plates were coated with 100 µg/ml human Coll-I 
(VitroCol) and blocked with sterile 1% heat denatured BSA. Wells 
for analysis in the absence of ECM were left uncoated.
Immobilized anti-integrin antibodies can be used as integrin 
agonists (37–40). Therefore, to selectively analyze engagement of 
specific integrins, plates were coated with goat anti-mouse IgG 
monoclonal antibody overnight at 4°C, washed with PBS, and 
coated for 2 h at room temperature with either 20 µg/ml of anti-
integrin α2β1 (clone BHA2.1) antibody or anti-integrin α3β1 (clone 
M-KID2) antibody, both from Millipore (Hertfordshire, UK).
Measurement of MMP and TiMP 
concentrations
At 24 h post-stimulation, MMP and TIMP concentrations were 
analyzed by ELISA (Duoset, R&D Systems, Abdingdon, UK) or 
by Luminex bead array (Luminex 200, Bio-Rad, Hertfordshire, 
UK) using the Fluorokine MAP kit (R&D Systems) according to 
manufacturer’s instructions. Lower limits of sensitivity for the 
Duoset kits are: 21.2 pg/ml for TIMP-1, 31.2 pg/ml for TIMP-2, 
and 156 pg/ml for MMP-1. In the Fluorokine Luminex kit, the 
lower limits are: 1.1 pg/ml for MMP-1, 12.6 pg/ml for MMP-2, 
7.3  pg/ml for MMP-3, and 13.7  pg/ml for MMP-9. Samples 
were within the linear range of detection as indicated by the 
manufacturer.
Detection of collagenase activity
Matrix metalloproteinase-1 collagenolytic activity was measured 
using EnzChek DQ Coll-I assay (Thermo Fisher Scientific) per-
formed as indicated in the manufacturer’s instructions. Briefly, 
a standard curve was generated from known concentrations of 
collagenase from Clostridium histolyticum and standards and cell 
supernatants were incubated with DQ type I collagen for 24 h. 
Gain of fluorescence originated from DQ collagen degradation. 
Mean basal collagenase activity from controls was subtracted 
from CoMtb-stimulated wells without ECM and type I collagen, 
respectively, and fold-change in collagenase activity was calcu-
lated relative to CoMtb-stimulated wells in the absence of ECM.
reverse Transcription and real-Time Pcr
After 6  h incubation, HBEC cells were lysed with TRI-reagent 
and total RNA extracted using PureLink RNA Mini Kit (Thermo 
Fisher Scientific). 1  µg RNA was reverse transcribed using 
QuantiTect Reverse Transcriptase Kit (Qiagen, Manchester, UK) 
and qPCR reactions were performed in the ABI Prism 7700 
(Applied Biosystems, Paisley, UK). MMP-1 cycle thresholds were 
quantified by comparison to an MMP-1 standard curve gener-
ated using known MMP-1 concentrations and standardized to 
18S rRNA. MMP-1 primers and probes were custom made and 
supplied by Sigma-Aldrich (forward primer: 5′-AAGATGAAA 
GGTGGACCAACAATT-3′; reverse primer: 5′-CCAAGAGA 
ATGGCCGAGTTC-3′; probe: 5′-FAM-CAGAGAGTACAACTT 
ACATCGTGTTGCGGCTC-TAMRA-3′) and 18S rRNA primer 
and probe mix was supplied by Thermo Fisher Scientific.
Flow cytometry
HBEC cells were detached with 5  mM EDTA, washed with 
PBS, fixed with 4% paraformaldehyde (w/v), and blocked with 
1% BSA/5% human serum (v/v) buffer. Cells were incubated 
for 1 h at room temperature with FITC-conjugated anti-human 
integrin antibody or mouse IgG1 isotype control antibody. Flow 
cyto metry was performed on a FACSCalibur (BD Biosciences, 
UK) cytometer. The baseline Forward Scatter, Side Scatter, and 
FL1H settings were adjusted using an unstained, unstimulated 
cell sample. Mean fluorescence intensities (MFI) were compared 
after normalization to the isotype control. Data were analyzed 
using FlowJo vX.0.6 (Tree star, Ashland, OR, USA).
confocal Microscopy
4-well glass slides were pre-coated with Coll-I and HBEC cells 
seeded and incubated as described. Cells were fixed, blocked, 
and stained with FITC-conjugated anti-integrin or mouse IgG1 
isotype control antibody. MMP-1 was stained with a rabbit 
anti-human MMP-1 primary antibody (Millipore) and Cy5-
goat anti-rabbit IgG (Abcam) as secondary antibody. Staining 
with secondary antibody alone was used as control. For F-actin 
staining, cells were permeabilized with 0.5% saponin (v/v) and 
stained with phalloidin conjugated with Alexa Fluor 594 (Thermo 
Fisher Scientific). DAPI was used as nuclear counterstain. Slides 
were scanned using a 63× oil immersion objective and to avoid 
bleed-through effects, each dye was scanned independently in 
a Leica TCS SP5 confocal microscope equipped with 405  nm 
diode laser, 488 nm argon laser, 543 and 633 nm HeNe lasers, 
and using the Leica Application Suite 2.6.2 software (Milton 
Keynes, UK). Images were edited using ImageJ software v1.46r 
(NIH, MD, USA).
Wound healing assay
96-well ImageLock plates (Essen Biosciences Ltd., Hertfordshire, 
UK) were coated with Coll-I or poly-l-lysine and cells were 
seeded as described. A standard wound was created in each cell 
monolayer using a WoundMaker (Essen Bioscience Ltd.) accord-
ing to manufacturer’s protocol. Cells were stimulated and/or 
soluble Coll-I was added (sColl-I). Plates were incubated in the 
IncuCyte Zoom (Essen Biosciences Ltd.). Images were taken at 
2 h intervals for a maximum of 24 h.
histology and immunohistochemistry
Lung biopsy specimens were collected as part of routine clini-
cal care of patients who were subsequently diagnosed with TB. 
Patients gave consent for the residual paraffin embedded tissue 
blocks not required for diagnostic purposes, to be analyzed 
in this study. The study was approved by the NHS National 
Research Ethics Service (13/LO/0900) and University College 
London Hospitals Joint Research Office. Human control or 
Mtb-infected lung tissue blocks were cut into 5 μm sections 
and stained with Hematoxylin and Eosin (H&E) or modified 
Trichrome using an automated slide-stainer (Sakura, Tissue-
Tek DRS 2000). In brief, sections were stained with three dyes 
(Celestine blue/Ferric ammonium sulfate solution, Orange G/
Picric alcohol solution or Ponceau 2R/Acid fuchsin solution) 
to stained collagen (blue), red blood cells (yellow), cytoplasm 
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(red), and nuclei (dark red). Sections were also stained for 
integrin α2β1 and MMP-1. Anti-α2 integrin antibody (clone 
EPR5788, Abcam) was diluted 1/500 and applied for 15 min at 
room temperature following on-board epitope retrieval using 
Leica Epitope Retrieval Solution 2 (Leica, AR9640, pH9) for 
20 min at 99°C. Anti-MMP-1 antibody (clone 41-1E5, Millipore) 
was diluted 1/600 and applied for 15 min at room temperature 
 following on-board epitope retrieval using Leica Epitope 
Retrieval Solution 1 (Leica, AR9961, pH6) for 30 min at 99°C. 
Control sections were treated in exactly the same way as other 
sections but isotype-dependent non-specific primary antibody 
binding was controlled for using species- and isotype-matched 
control antibodies at, at least, the same concentration as that of 
the primary antibody being controlled for. Specifically, these 
were a polyclonal rabbit immunoglobulin at 10 μg/ml as control 
for anti-α2β1; and a mouse IgG2a at 10 μg/ml to control for 
anti-MMP-1. All immunostaining was carried out on the Leica 
Bond III automated platform, using the Leica Bond Polymer 
Refine detection system (Leica, DS9800), which includes a per-
oxide block, a serum block, and a two-step rabbit anti-mouse 
post-primary/anti-rabbit polymer amplification system with a 
DAB chromogen.
All slides were scanned on a Nanozoomer Digital Slide 
Scanner and images analyzed using NDP.viewer software (both 
from Hamamatsu Corportation). Sections were inspected by 
a “blinded” reviewer and five airways from each subject were 
randomly selected for visual analysis. Representative images were 
chosen from those selected.
statistical analysis
Data analysis was performed using GraphPad Prism v5.02 
(GraphPad Inc., USA). Data are presented as mean ± SD of three 
replicate samples and are representative of three independent 
experiments unless otherwise stated. Statistical analysis was 
performed using one-way ANOVA and Tukey’s range test. 
For experiments with two independent variables, analysis was 
performed using a two-way ANOVA and Bonferroni correction 
for multiple comparisons. Differences between variables were 
considered statistically significant for p-values < 0.05. p-Values 
are represented as follows: *p < 0.05, **p < 0.01, ***p < 0.001; 
****p < 0.0001.
resUlTs
Bronchial epithelial cells on a Type i 
collagen Matrix Downregulate  
coMtb-induced collagenase activity
First, we analyzed respiratory epithelial cell-derived collagenase 
activity following CoMtb stimulation, both when HBECs were 
adherent to an intact type I collagen matrix (mColl-I) and in 
the absence of such matrix. In CoMtb-stimulated HBECs, colla-
genase activity was decreased by 87.4% when cells were cultured 
on mColl-I, compared to cells cultured in the absence of ECM 
(w/o ECM; Figure 1A; p < 0.01).
Matrix metalloproteinase-1 is the principal collagenase 
released by respiratory epithelial cells and associated with tissue 
destruction in TB (14); therefore, we next investigated this col-
lagenase. CoMtb induced secretion of MMP-1 by HBECs, which 
was reduced by 32% (p < 0.001), when HBECs were cultured on 
mColl-I (Figure 1B). In addition, mColl-I decreased MMP-1 RNA 
expression by 49% in CoMtb-stimulated HBECs demonstrating 
an effect at the gene expression level (p <  0.0001; Figure  1C). 
Furthermore, in HBECs adherent to mColl-I, MMP-1 localiza-
tion was focal instead of diffuse (Figure 1D).
Matrix remodeling may be critically regulated by MMP:TIMP 
ratios (15). Therefore, we investigated the effect of adhesion to 
ECM on secretion of TIMP-1/2, the main secreted inhibitors 
of MMP-1. Neither the addition of CoMtb nor the presence or 
absence of mColl-I (Figures 1E,F) affected TIMP-1/2 secretion 
by HBECs.
coMtb-induced secretion of MMP-1  
by hBecs is regulated by signaling of 
integrin α2β1 and the actin cytoskeleton
Next, we investigated the possibility that signaling through 
collagen-binding integrins expressed by HBECs might regulate 
MMP-1. Plates were either left uncoated, or coated with mColl-I, 
with antibodies to α2β1 or with antibodies to α3β1 integrins. 
CoMtb-stimulated HBECs adherent to anti-α2β1 antibodies had 
decreased MMP-1 gene expression and secretion to cells adherent 
to mColl-I. In contrast, adhesion to coated anti-α3β1 antibodies 
resulted in high level MMP-1 gene expression and secretion, 
similar to that observed in the absence of ECM (Figures 2A,B).
The actin cytoskeleton is an important component of down-
stream integrin signaling. To examine cytoskeletal involvement 
in CoMtb-stimulated α2β1-dependent MMP-1 secretion, we next 
inhibited F-actin polymerization using 4 µg/ml cytochalasin D 
(Figure  2C). F-actin inhibition decreased the baseline MMP-1 
secretion after CoMtb stimulation by approximately 30% (from 
3,198.4 ± 238 to 2,229.7 ± 269 pg/ml; p < 0.001) in HBECs not 
adherent to ECM. In addition, Cytochalasin D prevented further 
inhibition of MMP-1 secretion when cells were cultured on 
mColl-I, which suggests a role for the actin cytoskeleton in the 
α2β1-mediated inhibition of MMP-1 expression.
Next, we investigated the effects of CoMtb on the surface 
expression and distribution of integrin α2β1, as well as F-actin 
polymerization with adhesion to collagen. Confocal microscopy 
revealed that in the absence of ECM, CoMtb-stimulated HBECs 
had a lower signal from integrin α2β1 (Figure 3A). In HBECs 
cultured on mColl-I, integrin α2β1 was mainly at the cell–matrix 
interface co-localizing with F-actin.
However, there were no significant differences in MFIs by 
FACS for the α2 integrin subunits in the presence or absence of 
matrix (Figure 3B), indicating that the increase in signal detected 
by confocal microscopy was principally due to clustering of inte-
grins. As expected, no differences were seen in expression of the 
α3 subunit (Figure 3C).
These results indicate that the modulation of MMP-1 gene 
expression and secretion by mColl-I in CoMtb-stimulated HBECs 
is not due to increased expression of integrin α2β1, but due to 
matrix-induced clustering of integrin α2β1 and subsequent actin 
polymerization at the sites of adhesion.
FigUre 1 | Collagen matrix regulates collagenase activity and matrix metalloproteinase (MMP)-1 expression in CoMtb-stimulated human bronchial epithelial  
cells (HBECs). HBECs were cultured in the presence of matrix type I collagen (mColl-I) or without extracellular matrix (ECM) and stimulated with CoMtb or control 
medium (CoMCont). Supernatants were collected at 24 h for analysis of collagenolytic activity and protein secretion, while cell lysates were collected at 6 h for total 
RNA extraction and analysis of MMP-1 gene expression. (a) Fold-change in collagenase activity. Basal collagenase activity in control HBECs was subtracted from 
respective CoMtb-stimulated wells. Fold-change is relative to mean collagenolytic activity from cells in the absence of ECM. (B) MMP-1 secretion (pg/ml).  
(c) Fold-change in MMP-1 mRNA accumulation, normalized to 18S mRNA as reference control. Fold-change is relative to mean MMP-1 expression in control wells 
without ECM. (D) Confocal microscopy images from control (CoMCont) and CoMtb-stimulated HBECs cultured in the presence or absence of matrix Coll-I (n = 2). 
Slides were stained with DAPI (blue) for nucleic acids and anti-MMP-1 primary antibody and Cy5 conjugated anti-rabbit secondary antibody (red). Scale bar: 50 µm. 
(e) Tissue inhibitors of metalloproteinases (TIMP)-1 and (F) TIMP-2 secretion. Plots show mean and SD of assays performed in triplicate, which were replicated on 
three occasions. p-Values were obtained with one-way ANOVA with Tukey’s range test. **p < 0.01; ***p < 0.001; ****p < 0.0001.
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FigUre 2 | CoMtb-driven matrix metalloproteinase (MMP)-1 gene expression 
and secretion is regulated by integrin α2β1 and actin cytoskeleton. Human 
bronchial epithelial cells (HBECs) were seeded in matrix type I collagen (mColl-I) 
or wells coated with anti-integrin antibodies and stimulated with CoMtb or 
control medium. (a) MMP-1 secretion from HBECs in the presence or absence 
of coated anti-integrin α2β1 or anti-α3β1 antibodies. (B) Fold-change in MMP-1 
mRNA accumulation in the presence or absence of coated anti-integrin α2β1 or 
anti-α3β1 antibodies. MMP-1 mRNA copies were normalized to 18S mRNA 
and fold-change is relative to mean MMP-1 expression in control wells without 
extracellular matrix. (c) MMP-1 from HBECs pre-incubated for 2 h with 4 µg/ml 
cytochalasin D before stimulation with CoMtb for 24 h. This figure shows 
fold-change relative to mean MMP-1 secretion by the respective controls in the 
absence of CoMtb. Plots show mean and SD of assays performed in triplicate, 
which were replicated on three occasions. p-Values were obtained with 
one-way ANOVA with Tukey’s range test. ***p < 0.001; ****p < 0.001.
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airways With reduced Bronchial collagen 
Matrix appear to have Further increased 
epithelial MMP-1 expression in lung 
Biopsies of TB Patients
To investigate the relevance of these findings in human TB infec-
tion in patients, type I collagen and integrin α2β1 expression were 
analyzed in lung biopsies from TB patients (n =  5) compared 
with control lung sections (n  =  2). Clinical data on the TB 
patients and controls are summarized on supplementary Table 
S1 in Supplementary Material. Tissue remodeling was seen in 
association with and adjacent to bronchial epithelial cells in TB 
as demonstrated by H&E staining (Figure 4; Figures S1 and S2 
in Supplementary Material). The bronchial epithelium stained 
strongly for integrin α2β1 and, consistent with data from cellular 
studies, overall staining of integrin α2β1 was similar between 
controls and TB patients. Furthermore, in biopsies from TB 
patients, there were airways with altered collagen matrix com-
pared to controls (middle and right hand panels), and areas of 
increased MMP-1 staining.
hBec interactions With a Type i collagen 
Matrix enhances cell Migration and 
Wound repair in TB
Finally, to investigate the functional consequences of adhesion 
to an intact matrix in TB, a model of bronchial epithelial wound 
healing was developed using HBECs either adherent to mColl-I 
or cultured in the absence of ECM (poly-l-lysine coated wells). 
Following stimulation by CoMtb, HBECs cultured on mColl-I 
migrated faster than cells cultured in the absence of ECM, taking 
approximately 14 h to close the wound (Figures 5A,B). No dif-
ference in the rate of migration was seen in controls between the 
conditions (Figure S3 in Supplementary Material). To confirm that 
an intact matrix was required for this increase in cell migration, 
HBECs were also cultured on poly-l-lysine and type I collagen 
was added in solution (sColl-I). In the presence of sColl-I, HBECs 
migrated even more slowly than the corresponding cells in the 
absence of ECM, with only a 45% relative wound coverage after 
14 h. Migration was mediated by MMP activity, since pretreat-
ment of cultures with 10 µM GM6001 inhibited cell migration in 
the presence or absence of mColl or sColl (Figure 5C).
DiscUssiOn
In TB, epithelial repair is a key process in healing from active TB, 
which may follow extensive destruction of the ECM. Previous 
studies have identified MMP-1 activity, from multiple cell types, 
including respiratory epithelial cells, as having a key role in 
tuberculosis-associated tissue destruction (10, 14). In this study, 
we demonstrate that the interaction between the cell and the col-
lagen matrix is an important factor regulating respiratory epithe-
lial response to Mtb-infection. In particular, we describe a process 
by which immobilized mColl-I modulates MMP-1 secretion, 
activity, and localization in response to CoMtb, via integrin α2β1 
and the actin cytoskeleton. This is consistent with accumulating 
evidence that the ECM environment is at least as important in 
regulation of cellular function as soluble factors (41).
FigUre 3 | Matrix type I collagen induces α2β1 integrin clustering and actin colocalization without affecting integrin surface expression. Human bronchial epithelial 
cells (HBECs) were cultured in the in the presence of matrix or soluble Coll-I or without extracellular matrix (ECM) as controls and stimulated with CoMtb or control 
medium. (a) Confocal microscopy figures of CoMtb-stimulated HBECs. Cells were stained with DAPI (blue) for nucleic acids, phalloidin conjugated with Alexa Fluor 
594 (red) for F-actin, and FITC-conjugated anti-integrin α2 antibodies (green) for integrin subunit α2. Yellow color shows co-localization of F-actin and integrin α2β1 
in merged images. Scale bar: 50 µm. (B,c) Control and CoMtb-stimulated HBECs were labeled with FITC-conjugated anti-integrin α2 or α3 and analyzed by FACS. 
FITC-conjugated mouse IgG1 was used as isotype control. Plots show mean fluorescence intensities (MFI) and SD for (B) α2 and (c) α3 integrins of three 
independent experiments.
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Our data show that respiratory epithelial cell MMP-1 gene 
expression and secretion are modulated by cell adhesion to 
the ECM. Adhesion to type I collagen was associated with 
decreased collagenolytic activity and MMP-1 gene expression, 
and pericellular, focal localization. The secretion of MMP-1 
inhibitors -TIMP-1/2- was not decreased by CoMtb-stimulation 
of HBECs, which is likely to further contribute to matrix 
preservation.
The effect on CoMtb-driven MMP-1 expression following 
airway epithelial adhesion to matrix collagen was integrin 
dependent. MMP-1 secretion was regulated by integrin α2β1 
but not by integrin α3β1, the other collagen-binding integrin 
expressed on respiratory epithelial cells. The presence of CoMtb 
did not alter the surface expression of integrin α2β1 and so the 
effects on MMP-1 expression appear to be due to events after 
ligand binding. Furthermore, cytochalasin D, which blocks actin 
polymerization, reduced baseline MMP-1 secretion, but no fur-
ther reduction was seen when cells are cultured on mColl-I. Thus, 
MMP-1 secretion seen when HBECs are stimulated with CoMtb 
appears to be dependent on actin polymerization, and modulated 
by integrin α2β1 signaling. In migrating keratinocytes, there is 
direct binding of pro-MMP-1 to integrin α2β1. The ternary 
complex formed between integrin α2β1, type I collagen, and 
pro-MMP-1 spatially confines proteolysis to specific points of 
cell-matrix contacts, which allows directed cell migration and 
re-epithelization, and this may also be important for bronchial 
epithelial preservation in TB (42–44).
It is well known that mechanical changes in contractile protein 
expression allow epithelial cells to respond to the mechanical 
properties of the ECM during tissue repair. These changes are 
brought about by integrin signaling from the ECM environment 
(outside-in). Integrin signals can activate different pathways 
such as the extracellular signal-regulated kinase (ERK)/mitogen- 
activated protein kinase (MAPK) or the PI3K/Akt pathways (45), 
and these pathways are also involved in upregulation of MMP 
expression in tuberculosis (18, 36). One study investigating 
modulation of MMP-9 by α3β1 integrin in malignancy, using 
immortalized mouse keratinocytes, demonstrated that α3β1 
signaling leads to an increase in MMP-9 mRNA stability by 
activation of the MEK/ERK pathway (46).
In a study using airway smooth muscle (ASM) cells from 
asthma and control patients, stimulation with Tenascin-C induced 
FigUre 4 | Matrix metalloproteinases (MMP)-1 is further increased in lung 
tissue sections with altered collagen staining from Mtb-infected patients. 
Paraffin-embedded lung tissue blocks from Mtb (n = 5) and control (n = 2) 
patients were sectioned into 5 µm slices and stained for Hematoxylin and 
Eosin (H&E), integrin α2β1 (1/500 anti-α2 antibody, clone EPR5788) (brown), 
MMP-1 (1/600 anti-MMP-1 antibody, clone 41-1E5) (brown), and modified 
Trichrome stain, which stains collagen (blue). Sections were inspected by 
a “blinded” reviewer and five airways from each individual were randomly 
selected for visual analysis. Staining of α2β1 (brown) was similar between 
Mtb patients and controls but MMP-1 (brown) is increased in Mtb patients. 
This figure shows representative images from a control lung (left panels) and 
two Mtb lungs (middle and right panels). Images are shown at 20× with 
inset shown at 10× magnification. Images were analyzed with the NDP.
viewer software. Scale bars: 250 µm for images at 10× and 100 µm for 
images at 20×.
8
Brilha et al. Bronchial Repair in TB
Frontiers in Immunology | www.frontiersin.org June 2018 | Volume 9 | Article 1348
greater MMP-1 expression by asthma patient ASM-derived cells, 
via JNK, p38, and ERK1/2 MAPKs signaling, and blocking β1 
and β3 integrins decreased this response (47). Downstream of 
integrin α2β1, Cdc42 signaling was shown to decrease MMP-1 
expression through Erk-1/2 inhibition in activated keratinocytes 
and dermal fibroblasts on type I collagen (48, 49). Integrins may 
also activate the PI3K pathway through the focal adhesion kinase, 
and our group has previously shown that PI3K is an important 
negative regulator of MMP-1 and its blockade leads to MMP-1 
upregulation in CoMtb-stimulated NHBE cells (36). Together, 
these studies indicate that changes in the ECM due to chronic 
inflammation or infection can affect integrin signaling and MMP 
expression, which ultimately can impact lung repair. In  particular, 
MMPs are upregulated as cells transition into a more motile 
phenotype but are downregulated by factors that promote cell 
tension and actin formation, such as a collagen ECM; however, 
the precise mechanisms by which this is achieved is unclear and 
the subject of future work.
The cellular data were supported by findings in lung biopsies 
from TB patients, where staining of integrin α2β1 was clearly 
demonstrated in TB. Integrin α2β1 expression levels were  similar 
between the bronchial epithelium of controls and TB patients 
consistent with there being no changes in total α2β1 detected in the 
cellular system. MMP-1 expression was increased in the bronchial 
epithelium of TB patients with some reduction in subepithelial 
collagen ECM staining compared to control subjects. This may be 
due to inflammatory MMP activity causing tissue destruction and 
a subsequent reduction in the α2β1 integrin-mediated regulation of 
MMP-1 that we have demonstrated in vitro.
Airway epithelium repair is a complex process, and cell–
matrix interactions have to be strictly controlled to confer an 
adequate cell adhesion to the ECM (50). CoMtb-stimulated 
HBECs seeded on a type I collagen matrix had a greater migra-
tory ability in a wound healing assay than cells in the absence of 
ECM. Both integrin occupancy and clustering by immobilized 
matrix type I collagen were required for this response since 
addition of type I collagen in solution (sColl-I) decreased 
HBECs migratory ability when compared with cells adher-
ent to mColl-I. A study investigating the role of MMP-7 and 
Sydecan-1 in lung repair, using organotypic airway  cultures, 
reported that the activation state of α2β1 integrin can either 
promote or prevent airway epithelial cell migration and 
wound closure (51), which indicates that for migration and 
re-epithelization, the type of interaction between the integrin 
α2β1 and the ECM may induce different downstream signaling 
and actin reorganization, which can either cause cell spreading 
or promote cell migration.
The fact that sColl had quite different effects in this model of 
TB and did not drive respiratory epithelial repair suggests that 
destroyed collagen, characteristic of severe human disease, may 
lead to further tissue damage and not healing. These findings are 
consistent with those reported in aged skin in which fragmenta-
tion of collagen with age leads to increased MMP-1 secretion, and 
further skin damage (52).
Proteolysis of the ECM is necessary for cell migration, but 
in TB, excessive proteolysis of the ECM is associated with 
tissue damage (4, 53). The differential effects of MMP-1 secre-
tion mediated by mColl-I and integrin α2β1 clustering show a 
previously unrecognized role for the ECM in tissue repair in TB. 
These findings are consistent with studies in dermal wounds, 
where MMP-1 secretion may promote cell migration, while 
high-level expression of MMP-1 impedes tissue repair and are 
associated with chronic non-healing wounds (49, 54). Here, 
we show that although type I collagen reduces MMP-1 expres-
sion, the MMP-1 is more focally concentrated. Integrin α2β1 
is known to bind MMP-1 (42), and this may concentrate the 
collagenolytic activity at the leading edge of the cell. By binding 
both the substrate ( collagen) and the enzyme (MMP-1), the 
integrin is able to focus the collagenase activity and promote 
wound healing while reducing bystander tissue destruction.
In summary, our data show that, in TB, an intact collagen 
matrix signaling through the α2β1 integrin and the actin 
cytoskeleton is important in bronchial epithelial cell migration 
and tissue repair. Understanding such mechanisms involved in 
the balance of tissue destruction and repair in TB is crucial for 
development of new therapeutic approaches capable of tackling 
immunopathology, and to decrease morbidity and mortality 
when used in combination with anti-tuberculous therapy.
FigUre 5 | Type I collagen matrix enhances respiratory epithelial cell migration and wound repair in TB. Human bronchial epithelial cells (HBECs) were cultured in 
the absence of matrix [w/o extracellular matrix (ECM)] or in the presence of matrix type I collagen (mColl-I). Wells without mColl-I were pre-coated with poly-l-lysin. 
Collagen in solution was also added as control (sColl-I). Cells were stimulated with CoMtb with or without 10 µM GM6001. Images were acquired at 2 h intervals 
from wound creation and figures shown time 0–14 h. (a) Images acquired at time 0 and 12 h post-wound creation from CoMtb stimulated HBECs w/o ECM, with 
mColl-I or sColl-I and 10 µM GM6001. Scale bars: 400 µm. Relative wound density coverage was analyzed for wells with: (B) CoMtb; or (c) CoMtb and 10 µM 
GM6001chemical inhibitor. Relative wound density correspond to the amount of wound coverage by migrating cells. Plots show means and SD of four replicate 
wells and are representative of at least two independent experiments. p-Values were obtained with a two-way ANOVA, with Bonferroni correction for multiple 
comparisons. *p-value <0.05, ****p-value < 0.0001.
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